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Abstract
Objectives To present the most important characteristics of
inflammatory myofibroblastic tumours (IMTs) arising in dif-
ferent locations of the body with histological correlation.
Methods To review the symptoms and main radiological find-
ings of IMTs. On ultrasonography (US), these tumours can
appear as hypoechoic or hyperechoic masses and a variable
Doppler appearance with increased vascularity. Computed
tomography (CT) and magnetic resonance (MR) are the most
used imaging tools in their evaluation. On contrast-enhanced
CT, IMTs can appear as homogeneous or heterogeneous le-
sions, with variable enhancement on delayed acquisitions due
to fibrosis. These findings are also present on gadolinium
contrast-enhanced MR. On T1-weighted and T2-weighted
sequences, IMTs usually show low signal intensity reflecting
also the presence of fibrotic tissue.
Results To show the main clinical symptoms and radiological
features of IMTs in different locations: head and neck, lung,
genitourinary, hepatic, splenic, gastrointestinal tract, mesen-
teric, muskuloskeletal.
Conclusions Although IMTs in some organs are not uncom-
mon, they are not usually included in the differential diagnosis
of masses. Their radiological features suggest malignant neo-
plasms, whereas they are not. Consequently, this is an
underdiagnosed entity and only after an histological exam
could a definitive diagnosis be achieved.
Teaching Points
• Their radiological features suggest malignant neoplasms,
whereas they are not
• CT and MR imaging are the most used tools in their
evaluation
• IMT is an underdiagnosed entity
• The definitive diagnosis is only after histological exam
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Introduction
Inflammatory myofibroblastic tumours (IMTs) constitute a
rare group of neoplasms composed of a mixture of spindle-
shaped myofibroblasts or fibroblasts and a variable amount of
inflammatory cells (eosinophils, plasma cells and lympho-
cytes) [1]. Many different terms have been used to refer to
these tumours: plasma cell granuloma, inflammatory
myofibrohistiocytic proliferation, fibroxanthoma,
xanthogranuloma. However, nowadays IMT is the most ac-
cepted. The most frequently affected organs are lung and orbit
[2], but they have been described in nearly every organ.
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Different aetiologies have been proposed for IMT [3],
being different chronic infections, autoimmune diseases and
trauma the most accepted. Specific inflammatory diseases,
such as IgG4 disease, have also been recently associated [4,
5]. Little information exists about the natural history of this
entity. In some cases, an aggressive behaviour with metastases
has been described [3, 6, 7].
Clinical presentation of IMTs depends on the organ in
which they arise, but they frequently associate general inflam-
matory symptoms as fever or malaise.
Radiological appearance of IMTs is unspecific and they are
often misdiagnosed as malignant neoplasms. Many of them
are incidentally discovered when an imaging technique (com-
puted tomography [CT], ultrasonography [US] or magnetic
resonance imaging [MRI]) is performed for any other reason.
Their most common radiological presentation is as solid,
irregular, well-defined masses.
Histological studies are critical to properly diagnose them.
Immunohistochemical studies of T- and B-cell subpopula-
tions, CD34, CD117, S-100 and c-Kit may be helpful in
distinguishing IMTs from other soft-tissue neoplasms [8, 9].
At the molecular level, approximately half of IMTs contain a
clonal cytogenetic aberration that activates the anaplastic lym-
phoma kinase (ALK-) [9]. Positive immunohistochemical
staining of ALK is in approximately 40–100 % of IMTs,
depending on the anatomical sites where they arise [8–10].
This finding suggests a possible neoplastic cause of IMTs.
Furthermore, ALK expression could be a prognostic factor of
aggressiveness for IMT.
According to an update based on the new World Health
Organisation (WHO) classification, IMTs are considered as
neoplasms which may recur or metastasise in as many as 5 %
of cases [11].
The objective of this pictorial review is to present the most
important characteristics of IMTs arising in different locations
of the body with their histological correlation.
Imaging techniques
The radiological findings of IMTs are non-specific. On US,
these tumours can appear as hypoechoic or hyperechoic
masses with ill-defined or well-circumscribed edges and a
variable Doppler appearance with increased vascularity. US
is usually the first imaging technique when IMTs appear in
specific locations, such as testicles or neck. In other locations
its role is limited except for the guidance of percutaneous
biopsies.
CT and MRI are the most used imaging tools in the eval-
uation of IMTs. On contrast-enhanced CT, IMTs can appear as
homogeneous or heterogeneous lesions, with variable en-
hancement on delayed acquisitions due to the presence of
fibrosis. These findings are also present on gadolinium
contrast-enhanced MRI. On T1-weighted and T2-weighted
sequences, IMTs usually show low signal intensity reflecting
also the presence of fibrotic tissue (Table 1).
IMTs in different locations of the body
Head and neck IMTs
IMTs have been reported in various sites in the head and neck
such as bucal space, maxillary sinus, nasal cavity, parotid
gland, nasopharynx and larynx (Fig. 1).
However, the orbit is the most common location of IMTs.
They account for approximately 10% of orbital masses, being
the third most common cause of orbital masses [12]. Their
aetiology is unknown, but they have been associated with
inmunological disorders, different infections and history of
trauma. Recently, they have been strongly associated with the
IgG4-related sclerosing systemic inflammatory disease [13]
and with chronic infection by Epstein-Barr virus [14].
The clinical presentation and symptoms may vary with the
location, extension and aggressiveness of the tumour. Patients
with IMTs of the orbit can present local symptoms as pain,
redness, oedema, proptosis, ptosis, oculomotor deficits, dip-
lopia, lid swelling or mass-effect and systemic symptoms due
to the general inflammatory disorders they are frequently
associated with [15].
CT and MRI are the imaging techniques of choice to
evaluate these lesions. Both of them provide information
about the exact location and extension of the mass. MRI is
superior to CT in the evaluation of inflammation of the nerves
and muscles [16].
They usually appear as solid and heterogeneous enhancing
masses, which can affect retro bulbar fat, cause bone destruc-
tion, and present intracranial extension [17]. When they show
low intensity on T2-weighted images prominent, fibrotic com-
position is present (Fig. 2).
Pathologically, IMTs of the head and neck consist of many
fibroblastic cells, fibroblastic cells and inflammatory cells,
which include plasma cells and eosinophils.
The differential diagnosis includes granulomatous dis-
eases, primary infection, sarcoid, Sjögren disease, primary
and secondary tumours of the orbit, lymphoma and connective
tissue diseases [16].
Treatment depends on its location and extension. The ad-
ministration of corticosteroids an inmunosupresors usually
leads to a decrease of size of the mass but also radiotherapy
or surgery may be indicated.
Pulmonary IMTs
Lung is one of the most common locations of IMTs. They
account for around the 50 % of benign pulmonary masses in
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children, representing only about 0.7 % of all tumours of the
lung in general population [18].
As in other organs, they are also associated with immuno-
logical disorders [18] and chronic infections [19]. Sometimes,
IMTs are also related with antecedents of lung surgery and
they can arise in surgical lung scars.
Common clinical characteristics include unspecific respi-
ratory symptoms, such as cough, chest pain, dyspnea,
Table 1 Symptoms, radiological findings and differential diagnosis of the main IMTs of the body
Symptoms Imaging findings Differential diagnosis
Orbit Pain, redness, oedema, proptosis,
ptosis, oculomotor deficits,
diplopia, swelling, mass-effect
Solid and heterogeneous enhancing.
Low intensity on T2-weighted due
to fibrotic composition. Associated
retrobulbar fat or oedema
Granulomatous diseases, primary
infection, sarcoid, Sjögren disease,
primary and secondary tumours
of the orbit, lymphoma and
connective tissue diseases




predominance for the lower lobes,
unusual calcifications. Heterogeneous
or homogeneous enhancement pattern.
Low intensity on T2-weighted images
Malignant lung masses: primary
bronchogenic carcinoma
Scrotum Lump in the scrotum Solid and heterogeneous masses with
internal vascularity on US. Well-defined,
hypodense, little enhancement on CT.




Heterogeneous or peripheral enhancement
during the arterial phase. Or homogeneous
enhancement during the arterial phase and
washout during the delayed phase on CT.
T1 hypointense and T2 hyperintense
with heterogeneous enhancement
HCC
Splenic Left upper quadrant or
epigastric pain
Low-density pattern. Low-intensity on the
T1- and T2-weighted images. Low-intensity
lesion in the early phase after gadolinium
injection and high-intensity in the
delayed phase
Splenic haemangioma and other
primary splenic neoplasms as






Hypodense, heterogeneous, well-delimited GIST, inflammatory fibroid polyp,
smooth muscle neoplasm, peripheral
nerve sheath tumour, solitary fibrous
tumour, fibromatosis, the follicular
dendritic cell sarcoma, lymphoma
and adenocarcinoma
Musculoskeletal Pain, oedema Non-homogeneous, solid Malignant lesions: rabdomyosarcoma
Fig. 1 PATHOLOGY: IMT in the left supraglottic space (arrow) with
paraglottic space involvement indicated by replacement of the paraglottic
fat with soft tissue. a Axial reformation of contrast-enhanced neck CT. A
solid, well-defined, little-enhancing nodule in the supraglottic larynx was
observed (yellow arrow). It did not seem to infiltrate adjacent structures. b
Microscopic study obtained after surgical removal of the lesion. The
sample showed proliferation of fusiform cells mixed with macrophages
and giant multinucleated cells. Small number of atypia andmitotic figures
were present. The tumour presented an expansive growth pattern. Normal
tissue was present in the peripheral zone (*)
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haemoptysis and unspecific inflammatory symptoms as fever,
malaise and weight loss.
The radiological presentation of lung IMTs is non-
specific. They usually appear as solitary, well-
circumscribed peripheral lung masses [20], with pre-
dominance for the lower lobes [21] (Fig. 3). Calcifica-
tion of the masses is unusual (about 15 %) [22]. It is
not frequent, but they can also be multiple. On CT with
intravenous contrast, they present a variable heteroge-
neous or homogeneous degree of enhancement pattern
[3, 21]. It has been described an aggressive behaviour
with invasion of the adjacent structures [15]. On MRI,
they present similar radiological findings as in other
locations. Because of their similar radiological appear-
ance to malignant lung masses, biopsy is necessary to
obtain the diagnosis.
The treatment of choice of lung IMTs is surgery to
exclude malignancy and to achieve the cure. Although
spontaneous regression may occur, local expansion may
cause significant morbidity and occasional death [23].
The prognosis after complete surgical resection is excel-
lent, with a low rate of recurrence. In these cases,
alternative treatments (radiotherapy, corticoids or chemo-
therapy) to surgery could be also used.
Genitourinary IMTs
Only a few cases of IMTs in the spermatic cord have
been reported. The most common presentation of epi-
didymal (Fig. 4) and paratesticular IMTs is a lump in
the scrotum.
In the evaluation of scrotal masses, US is the most accurate
imaging technique, helping to distinguish intratesticular from
extratesticular lesions and solid from cystic lesions. IMTs are
described as solid and heterogeneous masses with internal
vascularity [5]. On CT, they appear as well-defined,
hypodense masses with little enhancement after intravenous
contrast injection. In some cases, small calcifications can be
associated (Fig. 5).
Surgical resection without orchiectomy is the ideal
treatment, but in some cases the testicle must be re-
moved due to the size of the mass or when the mass is
attached to the testis.
Fig. 2 PATHOLOGY: IMT of
the left orbit. a, b Axial and
coronal MR reformations of the
same patient on T2-weighted
sequences showed a well-
delimited, hyperintense
intraorbital mass, in the intraconal
compartment, in the medial





injection. e Surgical sample
obtained after resection. f
Microscopic sample obtained
after surgery demonstrated an
epithelial tumour composed of
fusiform cells mixed with an
extensive chronic inflammatory
infiltrate of plasmatic cells,
lymphocytes and macrophages.
In the peripheral of the sample
striated muscle cells were also
observed
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IMTs of the penis are extremely rare. To our knowl-
edge, no IMTs at this location have been reported. We
have recorded only one case in our institution (Fig. 6).
On CT, this tumour appeared as a well-defined, little-
enhancing and non-aggressive mass surrounding the pe-
nile urethra and the corpora cavernosa with no evidence
of invasion of them.
Surgical treatment was performed due to the size and non-
conclusive radiological features of the tumour. Histological
studies confirmed the diagnosis of IMT.
Hepatic IMTs
Hepatic IMTs constitute an extremely rare group of
hepatic tumours, accounting only for the 0.7 % of all
the hepatic lesions [24]. They are more frequent in
young adults and Asian people. They have been
associated with autoimmune diseases, immunological
disorders and viral infections, such as IgG4 disease
[25], sclerosing cholangitis [26], Crohn′s disease, hepat-
ic viral infections [22] and Epstein-Barr virus [24].
Symptoms of hepatic IMTs depend on their size. Compres-
sion of adjacent hepatic structures has been described, pro-
ducing obstructive jaundice. Weight loss and fever have also
been reported [2].
CT and MRI are the most used imaging techniques.
Hepatic IMTs present different enhancement patterns
according to their vascularity. On contrast-enhanced
CT, they usually show heterogeneous or peripheral
enhancement during the arterial phase. Despite this,
some of them present homogeneous enhancement dur-
ing the arterial phase and washout during the delayed
phase, which can lead to misdiagnosing them as
hepatocarcinomas (HCCs) [27] (Fig. 7). On MRI, these
Fig. 3 PATHOLOGY: IMT of
the lung. A 55-year-old man with
a cough and haemoptysis.a Axial
reformation of non-contrast CT
with mediastinum window. Two
solid, ill-defined nodules in right
lower lobe are observed (yellow
arrows). Note the air brocogram
observed in the biggest mass. b
Axial reformations with lung
window of the same patient where
the lung nodules are shown (white
arrows). c Partial lobectomy of
the right lower lobe specimen.
Note the presence of the nodules
(*). dMicroscopic study of the
resected lung sample where
fusiform cells with an associated
inflammatory infiltrate of
lymphocytes, plasmatic cells and
histiocytes was found
Fig. 4 PATHOLOGY: IMTof the epididymus. A 40-year-old manwith a
lump in the scrotum. aA hypoechoic, well-delimited epididymal lesion in
the right scrotum was detected. b Sample of the epididymal lesion
obtained after surgical resection of the mass. A diffuse infiltrate com-
posed of fibroblastic and fusiform cells mixed with inflammatory cells
(mainly lymphocytes and macrophages) was observed
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Fig. 5 PATHOLOGY: paratesticular IMT. A 34-year-old man with
no relevant medical history came to our hospital with a lump in
the scrotum. a US showed an isoechoic, solid, paratesticular
nodule with fine calcifications (yellow arrow). It did not seem
to infiltrate the adjacent testicle. b Axial reformation of contrast-
enhanced CT on portal phase demonstrated a well-delimited,
heterogeneous, little-enhancing mass in the right scrotum. c
Surgical sample obtained after orchiectomy. d Microscopic study
of the lesion demonstrated a well-delimited lesion constituted of
fibroblasts, lymphocytes and plasmatic cells with associated
lymphoid follicle. There was no evidence of adjacent testicle
invasion
Fig. 6 PATHOLOGY: IMTof the penis. A 46-year-old man with a mass
in the penis came to our hospital. He related more than 6 years of slow
growth of the mass with no suspicious associated symptoms. a, b Axial
and coronal reformations of non-enhanced CT. Solid, well-defined, het-
erogeneous penile mass is shown. c, d Axial and coronal reformations of
enhanced-CT after the injection of intravenous contrast on portal phase.
The penile mass presents an heterogeneous and peripheral enhancement.
e Surgical sample obtained after partial penectomy. Macroscopic view
showed an heterogeneous aspect due to the mixture of tissues (solid
tumour, lipoid component and areas of haemorrhage). f Microscopic
study confirmed a mesenchymal tumour composed of fusiform cells,
some of them multinucleated, with round or elongate nucleus. Prominent
infiltrate of plasmatic cells and focal areas of haemorrhage were also
found. No mitotic figures were observed
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Fig. 7 PATHOLOGY: IMT of
the liver. Axial reformations of
T1-weighted MR before and after
intravenous gadolinium injection.
Well-defined, hypointense lesion
on T1-weighted images (a) which
presented weak enhancement in
the arterial phase (b) and wash-
out on portal and equilibrium
phases (c-, d) located in hepatic
left lobe. Capsule was present. e
Macroscopic view of partial
hepatectomy obtained after
surgical excision of the lesion. A
solid, well-defined and yellowing
appearance mass is showed. f The
lesion demostrated an expansive
chronic inflammatory infiltrate of
plasmatic cells, lymphocytes and
macrophages. The nearby
hepatocytes (*) were normal
Fig. 8 PATHOLOGY: hepatic
IMT. a Abdominal ultrasound
where a slightly hypoechoic,
solid, heterogeneous mass arising
in the left hepatic lobe was
observed. Axial T1-weighted
unenhanced (b) and contrast-
enhanced MR images (c, d)
showed an ill-defined with
heterogeneous enhancement mass
located in lateral hepatic
segments. e, fHistological sample
obtained after percutaneous
biopsy. Mesenchymal tumour
composed of fusiform cells,
lymphocytes and lipid-filled
macrophages can be observed.
Normal hepatocytes with large
and small fatty droplet change are
also present
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lesions usually are T1 hypointense and T2 hyperintense
with heterogeneous enhancement (Fig. 8). Hepatobiliary
contrast (Gadoxetate disodium, Primovist; Bayer
Healthcare, Leverkusen, Germany) could be of help to
differentiate HCC from IMTs of the liver. On the
hepatobiliary phase, high signal intensity in the centre
of the lesion has been described [27], suggesting a
benign lesion.
Surgery is the most accepted treatment. If there is a
biopsy-proven diagnosis of IMTs that excludes malig-
nancy, medical treatment with no steroidal anti-
inflammatory drugs in patients with peripheral hepatic
IMTs could be prescribed [28].
Splenic IMTs
Splenic IMTs are extremely rare. As in hepatic IMTs,
Epstein-Barr virus has been proposed as a possible
aetiological agent.
Patients with spleen IMTs frequently associate unspecific
symptoms as left upper quadrant or epigastric pain. Spleno-
megaly is common and some patients can present fever,
anaemia and signs of hypersplenism [29].
Different radiological imaging modalities have been
proposed for their evaluation. On all of them, the most
common radiological finding is a well-delimited mass.
On US, they look like echogenic or hypoechoic masses
Fig. 9 PATHOLOGY: IMT of the spleen. a Axial reformation of
contrast-enhanced CT on portal phase. Solid and well-defined lesion,
hypodense to the surrounding spleen parenchyma. b Sample obtained
with fine-needle aspiration. Prominent cellularity composed of an
irregular, weakly basophil set of mioepithelial-fusiform cells. Numerous
inflammatory cells (plasmatic, lymphocytes and few neutrophils and
eosinophils) with isolated macrophages were also found. No atypia or
mitotic figures were present
Fig. 10 PATHOLOGY: IMT of the stomach. Axial reformation of
contrast-enhanced CT on arterial (a), portal (b) and 3 min after injection
delayed (c) acquisitions. A well-defined, heterogeneous nodule with
moderate enhancement on portal phase arising from the gastric fundus
was found (yellow arrows). Diffuse liver steatosis can also be observed. d
Microscopic studies performed after surgical removal of the lesion dem-
onstrated high amount of mesenchymal fusiform cells combined with
vascular structures. Small focis of inflammatory infiltrates were present.
The lesion showed well-defined contours and an expansive growth
pattern
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[30]. On CT, they are depicted as low-density masses in
both non-enhanced and enhanced acquisitions (Fig. 9).
On MRI studies, they present low-intensity mass on
both the T1- and T2-weighted images. Their typical
enhancement pattern after gadolinium injection is as a
low-intensity lesion in the early phase, which changes
into a high-intensity one in the delayed phase [29].
The differential diagnosis includes splenic haemangioma
and other primary splenic neoplasms such as lymphoma or
splenic angiosarcoma [30].
Fig. 11 PATHOLOGY:
pararectal IMT. Axial and coronal
reformations of contrast-
enhanced CT on portal (a, b) and
8 min after injection delayed
acquisitions (c, d). Pararectal
solid and well-defined mass with
moderated peripheral
enhancement adjacent to the
rectum and left seminal vesicle
was detected. eMacroscopic view
of the tumour after surgical
resection. f Histological sample
obtained after biopsy.
Mesenchymal neoplasm
composed of polygonal cells with
clear cytoplasm and round
normochromatic nuclei with
abundant vessels and occasional
scattered inflammatory cells was
observed. Mixed within the
neoplasm cells, there was a
chronic inflammatory infiltrate of
lymphoid cells. There were no
foci of necrosis or mitotic figures
Fig. 12 PATHOLOGY: metastatic IMT of the appendix. A 63-year-old
man with antecedents of left hemicolectomy due to colon cancer. a Axial
reformation of contrast-enhanced CT on portal phase acquired seven
years after partial colectomy. An appendicular, irregular, solid mass with
slight enhancement was identified (yellow arrow). Due to its radiological
features, the lesion was diagnosed of appendicular carcinoma. The
patient did not perform surgery. b Axial reformation of contrast-
enhanced CT on portal phase performed 8 months later showed a
significant growth of the appendicular mass with extension and
infiltration of the adjacent small bowel loops. c Distant lymph-
adenopathy and liver metastases were present
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When a suspicious spleen mass is found, the treat-
ment of choice is splenectomy due to the high risk of
bleeding associated to splenic biopsy [8, 31]. The prog-
nosis of this entity after splenectomy has been consid-
ered excellent [29].
Gastrointestinal tract IMTs
IMTs of the gastrointestinal tract are infrequent. They can
arise anywhere, the stomach and small intestine being the
most common locations [3, 9].
Clinical symptoms may vary from none to abdominal pain,
intestinal obstruction, dysphagia or anaemia, depending on
the location and size of the mass. They also may present fever
and malaise.
Contrast-enhanced CT is the imaging technique, which
give us more information about of IMTs of the gastrointestinal
tract. They are usually found as hypodense, heterogeneous
and well-delimited masses (Figs. 10, 11 and 12).
The differential diagnosis of these tumours includes
GIST, inflammatory fibroid polyp, smooth muscle neo-
plasm, peripheral nerve sheath tumour, solitary fibrous
tumour, fibromatosis, the follicular dendritic cell sarco-
ma, lymphoma and adenocarcinomas [9]. In most of
these cases imaging features are not enough to diagnose
IMTs and biopsy or surgery are needed.
Surgery is the most accepted treatment. IMTs of the gas-
trointestinal tract present a higher recurrence rate than in other
locations of the body [29]. Other treatments, such as steroids,
non-steroidal anti-inflammatory drugs and thalidomide, have
been used in these tumours. Radiotherapy may have a place as
adjunctive therapy in local recurrence and incomplete surgical
removal [32].
IMTs of the appendix are extremely rare, with few
cases reported in the literature [9, 33, 34]. Chronic
infections, antecedents of trauma or surgery have been
proposed as possible aetiological factors [9]. Associa-
tions with acute appendicitis [35] and pseudomyxoma
[9] have been described.
Their radiological appearance is similar to the IMTs of
other gastrointestinal locations. Histological confirmation is
needed to achieve the diagnosis.
They usually have a benign clinical course with complete
resolution after appendicectomy. Extremely rare cases of
IMTs of the appendix showing local aggressiveness and me-
tastases have been reported [36] (Fig. 12).
Mesenteric IMTs
Mesentery is one of the most common locations of
extrapulmonary IMTs. They are more frequent in children
and young adults [37].
Many different aetiological factors have been proposed for
mesenteric IMTs [37, 38], such as chronic infections, autoim-
mune diseases and trauma. They frequently appear in patients
with previous surgery procedures [3, 39]. On contrast-
enhanced CT they usually appear as solid masses with hetero-
geneous enhancement pattern and ill- or well-definedmargins.
Their most frequent clinical presentation is as an abdominal
mass. They are often associated with a general inflammatory
response manifested with fever, weight loss and other symp-
toms that are related to the compressive effect of the tumour,
such as abdominal pain and vomiting.
Management of mesenteric IMTs is variable. Imaging,
usually CT. Rapidly growing tumours or symptomatic
ones needing treatment may follow from small tumours
which are not encroaching any nearby structures. Dif-
ferent treatments have been proposed: non-steroidal anti-
inflammatories, anti-oestrogens, chemotherapeutic agents
and surgery. Surgery remains as a useful modality al-
though quite a high local recurrence rate has been
described for tumours [3, 37, 38].
Fig. 13 PATHOLOGY: IMT of the iliopsoas muscle. a Axial and b
coronal reformations of contrast-enhanced CT where an ill-defined and
heterogeneous mass encompassing iliopsoas muscle and external iliac
vessels, mimicking malignant sarcomatous neoplasm was observed. c
Sample of the lesion obtained after surgical excision of the mass. Prolif-
eration of fibroblast with a diffuse infiltration of lymphocytes, eosinophils
and macrophages were found. No mitotic figures or cellular atypia were
present. The mass was well-defined and no signs of invasiveness were
found
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Musculoskeletal IMTs
Few cases have been described of IMTs arising from themuscles
[40]. Clinical manifestations usually are due to compression of
neighbouring organs. The symptoms that most often appear
include pain, haematuria, dysuria or urinary tract obstruction.
The radiological features do not help to distinguish them from
malignant neoplasms, such as rabdomyosarcomas (Fig. 13). Due
to its deep location, fine-needle biopsy may fail to yield a
sufficient volume of tumour tissue to achieve diagnosis.
Conclusions
Although IMTs in some organs are not uncommon, they are
not usually included in the differential diagnosis of nodules
and masses. Their radiological features suggest malignant
neoplasms, whereas they are not.
Consequently, this is an underdiagnosed entity and only after
an histological exam could definitive diagnosis be achieved.
It is fundamental for radiologists to know about the existence
of IMTs, as they frequently have better treatment options and
prognosis than the malignant neoplasms they are confused with.
Open Access This article is distributed under the terms of the Creative
Commons Attribution License which permits any use, distribution, and
reproduction in any medium, provided the original author(s) and the
source are credited.
References
1. Coffin CM, Flether JA (2002) Inflammatory myofibroblastic tumour.
In: Fletcher CDM, Unni KK, Mertens F (eds) World Health
Organization classification of tumours: pathology and genetics of
tumour of soft tissue and bone. IARC press, Lyon, pp 91–93
2. Narla LD, Newman B, Spottswood SS, Narla S, Kolli R (2003)
Inflammatory pseudotumour. Radiographics 23:719–729
3. Patnana M, Sevrukov AB, Elsayes KM, Viswanathan C, Lubner M,
Menias CO (2012) Inflammatory pseudotumour: the great mimicker.
AJR Am J Roentgenol 198:217–227
4. Li X, Wei S, Zhou Q, Chen J (2012) One case of multiple inflamma-
tory pseudotumour in both lungs. Zhongguo Fei Ai Za Zhi 15:246–248
5. Rafeek N, Joseph LD, Rajendiran S, Narayanan CD (2012)
Inflammatory myofibroblastic tumour of spermatic cord. Int J Surg
Case Rep 3:618–621
6. Coffin CM, Hornick JL, Fletcher CDM (2007) Inflammatory
myofibroblastic tumour: comparison of clinicopathologic, histologic,
and immunohistochemical features including ALK expression in
atypical and aggressive cases. Am J Surg Pathol 31:509–520
7. Rabban JT, Zaloudek CJ, Shekitka KM, Tavassoli FA (2005)
Inflammatory myofibroblastic tumour of the uterus: a clinicopatho-
logic study of 6 cases emphasizing distinction from aggressive mes-
enchymal tumours. Am J Surg Pathol 29:1348–1355
8. Alimoglu O, Cevikbas U (2003) Inflammatory pseudotumour of the
spleen: report of a case. Surg Today 33:960–964
9. Bonnet JP, Basset T, Dijoux D (1996) Abdominal inflammatory
myofibroblastic tumours in children: report of an appendiceal case
and review of the literature. J Pediatr Surg 31:1311–4
10. Cook JR, Dehner LP, Collins MH et al (2001) Anaplastic lymphoma
kinase (ALK) expression in the inflammatory myofibroblastic tu-
mour: a comparative immunohistochemical study. Am J Surg
Pathol 25(11):1364–1371
11. Fletcher CD (2014) The evolving classification of soft tissue tu-
mours—an update based on the new 2013 WHO classification.
Histopathology 64:2–11
12. Weber AL, Jakobiec FA, Sabates NR (1996) Pseudotumour of the
orbit. Neuroimaging Clin N Am 6:73–92
13. Pasquali T, Schoenfield L, Spalding SJ, Singh AD (2011) Orbital
inflammation in IgG4-related sclerosing disease. Orbit 30:258–260
14. Jin R, Zhao P, Ma X,Ma J,WuY, YangX, et al (2013) Quantification
of epstein-barr virus DNA in patients with idiopathic orbital inflam-
matory pseudotumour. PLoS One 8:e50812
15. Swamy BN, McCluskey P, Nemet A et al (2007) Idiopathic orbital
infammatory syndrome: clinical features and treatment outcomes. Br
J Ophthalmol 91:1667–1670
16. Weber AL, Romo LV, Sabates NR (1999) Pseudotumour of the orbit:
clinical, pathologic, and radiologic evaluation. Radiol Clin N Am 37:
151–168
17. Irisawa M, Yoshida A, Mabuchi N, Fujii K, Yoshioka H, Hamada T
et al (1989) MR imaging of orbital tumours. Nihon Igaku Hoshasen
Gakkai Zasshi 49:286–292
18. Toge M, Segawa M, Kusajima Y, Saito K, Inoue D, Doki Y,
Yoshimura N (2012) Immunoglobulin G4-related inflammatory
pseudotumour of the lung. Kyobu Geka 65:542–545
19. Philip J, Beasley MB, Dua S (2012) Mycobacterial spindle cell
pseudotumour of the lung. Chest 142:783–784
20. KaitoukovY, Rakovich G, Trahan S, Grégoire J (2011) Inflammatory
pseudotumour of the lung. Can Respir J 18:315–317
21. Agrons GA, Rosado-de-Christenson ML, Kirejczyk WM, Conran
RM, Stocker JT (1998) Pulmonary inflammatory pseudotumour:
radiologic features. Radiology 206:511–518
22. Kim TS, Han J, Kim GY, Lee KS, Kim H, Kim J (2005) Pulmonary
inflammatory pseudotumour (inflammatory myofibroblastic tu-
mour): CT features with pathologic correlation. J Comput Assist
Tomogr 29:633–639
23. Maurya V, Aditya Gupta U, Dewan RK, Jain S, Shah A (2013)
Spontaneous resolution of an inflammatory pseudotumour of the
lung subsequent to wedge biopsy. Arch Bronconeumol 49:31–34
24. Tang L, Lai EC, Cong WM, Li AJ, Fu SY, Pan ZY et al (2010)
Inflammatory myofibroblastic tumour of the liver: a cohort study.
World J Surg 34:309–313
25. Zen Y, Fujii T, Sato Y, Masuda S, Nakanuma Y (2007) Pathological
classification of hepatic inflammatory pseudotumour with respect to
IgG4-related disease. Mod Pathol 20:884–894
26. Zen Y, Harada K, Sasaki M, Sato Y, Tsuneyama K, Haratake J et al
(2004) IgG4-related sclerosing cholangitis with and without hepatic
inflammatory pseudotumour, and sclerosing pancreatitis-associated
sclerosing cholangitis: do they belong to a spectrum of sclerosing
pancreatitis? Am J Surg Pathol 28:1193–1203
27. Jeong JY, Sohn JH, Kim TY, Jeong WK, Kim J, Pyo JY et al (2012)
Hepatic inflammatory pseudotumour misinterpreted as hepatocellular
carcinoma. Clin Mol Hepatol 18:239–244
28. Tang L, Lai EC, Cong WM et al (2010) Inflammatory
myofibroblastic tumour of the liver: a cohort study. World J Surg
34:309–313
29. Moriyama S, Inayoshi A, Kurano R (2000) Inflammatory
pseudotumour of the spleen: report of a case. Surg Today 30:942–
946
30. Yan J, Peng C, Yang W, Wu C, Ding J, Shi T et al (2008)
Inflammatory pseudotumour of the spleen: report of 2 cases and
literature review. Can J Surg 51:75–76
Insights Imaging (2015) 6:85–96 95
31. Abbas T, Lateef M, Burhan-ul-Haq, Iftikhar F, Imtiaz U (2012)
Pseudotumour of spleen. J Coll Physicians Surg Pak 22:794–796
32. Ribeiro MC, Lopes LR, de Souza Neto JC, Meirelles LR, de
Carvalho RB, Andreollo NA (2012) Rare gastric inflammatory
myofibroblastic tumour in an adult woman: a case report with review
of the literature. Case Rep Med 2012:374070
33. Sanders BM, West KW, Gingalewski C, Engum S, Davis M,
Grosfeld JL (2001) Inflammatory pseudotumour of the alimen-
tary tract: clinical and surgical experience. J Pediatr Surg 36:
169–173
34. Majumdar K, Sakhuja P, Kaur S, Rastogi A, Gondal R,
Agarwal A (2012) Inflammatory myofibroblastic tumour ap-
pendix with concomitant mucosal dysplasia, simulating
pseudomyxoma on preoperative aspiration cytology. J Cancer
Res Ther 8:317–319
35. UludagM, Citgez B, Polat N (2008) Inflammatory pseudo-tumour of
the appendix and acute appendicitis: a case report. Acta Chir Belg
108:451–453
36. Vijayaraghavan R, Chandrashekar R, Belagavi CS (2006)
Inflammatory myofibroblastic tumour of appendix. J Clin Pathol
59:999–1000
37. Contreras De Miguel E, Gallardo Muñoz I, Espejo Pérez S, Seguí
Azpilcueta P, Contreras De Miguel E, Gallardo Muñoz I, Espejo
Pérez S, Seguí Azpilcueta P (2010) Unusual location of an inflam-
matory myofibroblastic tumour: a case report. Radiologia 52:473–
476
38. Choi AH, Bohn OL, Beddow TD, McHenry CR (2011)
Inflammatory myofibroblastic tumour of the small bowel mesentery:
an unusual cause of abdominal pain and uveitis. J Gastrointest Surg
15:584–588
39. Hirose Y, Kaida H, Kurata S, Okabe Y, Kage M, Ishibashi M (2012)
Incidental detection of rare mesenteric inflammatory pseudotumour
by (18)F-FDG PET. Hell J Nucl Med 15:247–250
40. Masciocchi C et al (2012) Soft-tissue inflammatory myofibroblastic
tumors (IMTs) of the limbs: potential and limits of diagnostic imag-
ing. Skelet Radiol 41:643–649
96 Insights Imaging (2015) 6:85–96
